Cargando…
Allergen immunotherapy for house dust mite-induced rhinitis: prescriptive criteria
Allergic rhinitis (AR) is a very common disease. In most cases, therapy is based on symptomatic drugs, while allergen immunotherapy (AIT), which is the only one to act on the cause of the disease, is reserved for patients with a greater burden of disease. In particular, the possible evolution toward...
Autores principales: | Incorvaia, Cristoforo, Ridolo, Erminia, Ciprandi, Giorgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182604/ https://www.ncbi.nlm.nih.gov/pubmed/33988150 http://dx.doi.org/10.23750/abm.v92i2.11011 |
Ejemplares similares
-
The Relevance of Nasal Cytology in the Workup of House Dust Mite-Induced Allergic Rhinitis
por: Gelardi, Matteo, et al.
Publicado: (2018) -
Allergic rhinitis: the eligible candidate to mite immunotherapy in the real world
por: Ciprandi, Giorgio, et al.
Publicado: (2017) -
Effect of high-dose sublingual immunotherapy on respiratory infections in children allergic to house dust mite
por: Barberi, Salvatore, et al.
Publicado: (2015) -
Preventive actions of allergen immunotherapy: the facts and the effects in search of evidence
por: Martignago, Irene, et al.
Publicado: (2017) -
Requirements for acquiring a high-quality house dust mite extract for allergen immunotherapy
por: Frati, Franco, et al.
Publicado: (2012)